To clarify this, we raised a function-blocking polyclonal antibody (pAb) that has been shown to block the interaction of ENO1 with plasminogen and its pro-migratory ability for cancer cells (32, 53), enabling us to specifically determine the functional importance of sENO1 in the invadopodia and the invasiveness of CSCs. The gene discussed is PLG; the disease is cancer.